Impact of a Physical Activity Program on the Health-Related Quality of Life in Pediatric Cancer Patients
Launched by SOCIEDAD DE LUCHA CONTRA EL CÁNCER · Feb 3, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a structured physical activity program can improve the quality of life for children and teens with cancer in Quito, Ecuador. The research aims to find out if participating in a supervised exercise program over 10 weeks can help these young patients feel better physically and emotionally, especially since many children with cancer do not get enough exercise. The study will involve 90 participants aged 8 to 18 who are either currently receiving treatment for cancer or are in the post-treatment phase.
Eligible participants must live in Quito and be treated at specific hospitals. Throughout the trial, all participants will fill out surveys to measure their health-related quality of life at the start, after completing the program, and a few months later. The goal is to gather important information that could help include physical activity as part of cancer care for young patients in similar settings. If you're considering participation, this study could be a valuable opportunity to help improve the health and well-being of pediatric cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age range: Participants must be between 8 and 18 years old at the start of the study.
- 2. Residency: Patients residing within the city limits of Quito, Ecuador. 3. Treatment status:
- • • Patients are being evaluated or treated at Hospitals SOLCA and Baca Ortiz.
- • Patients are either currently undergoing active treatment for pediatric malignancies, or
- • Patients are in the post-treatment phase after a pediatric cancer diagnosis.
- • The volunteer or a family member that lives with the possible participant has a cellphone so the survey can be administered and answered.
- Exclusion Criteria:
- • 1. The presence of a malignant solid tumor which has not yet been surgically addressed.
- • 2. A psychiatric diagnosis of cognitive impairment. 3. A diagnosis of osteosarcoma. 4. A history of cardiac pathology. 5. The patient is in the pediatric inpatient ward or was one month prior to the enrollment phase.
- • 6. The patient is stationed at the pediatric intensive care unit. 7. The patient received high-dose chemotherapy with methotrexate greater than 1000 mg/m2/dose or cytarabine greater than 1 g/m2/dose in the last month.
About Sociedad De Lucha Contra El Cáncer
The Sociedad de Lucha Contra el Cáncer (SLCC) is a prominent non-profit organization dedicated to the fight against cancer through research, education, and patient support. As a clinical trial sponsor, SLCC actively funds and oversees innovative research initiatives aimed at advancing cancer treatment and improving patient outcomes. With a commitment to fostering collaboration among healthcare professionals, researchers, and patients, SLCC plays a vital role in the development of new therapeutic strategies and the dissemination of critical information to enhance awareness and prevention efforts. Through its comprehensive approach, SLCC strives to make significant contributions to the global battle against cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quito, , Ecuador
Quito, Pichincha, Ecuador
Patients applied
Trial Officials
Gustavo Galárraga, MPH
Principal Investigator
Sociedad de Lucha Contra el Cáncer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported